Unraveling the complexities of the HDL lipidome(1)

von Kontush, Anatol, Lhomme, Marie, Chapman, M. John
Veröffentlicht 2013

The Year in Cardiology 2015: Prevention

von Chapman, M. John, Blankenberg, Stefan, Landmesser, Ulf
Veröffentlicht in Arq Bras Cardiol (2016)

Lipoprotein particles from the Golgi apparatus of guinea-pig liver

von Chapman, M. John, Mills, Gervase L., Taylaur, C. E.
Veröffentlicht 1972

The effect of a lipid-rich diet on the properties and composition of lipoprotein particles from the Golgi apparatus of guinea-pig liver

von Chapman, M. John, Mills, Gervase L., Taylaur, C. E.
Veröffentlicht 1973

LOCALIZATION OF THE ENZYMES OF KETOGENESIS IN RAT LIVER MITOCHONDRIA

von Chapman, M. John, Miller, Leonard R., Ontko, Joseph A.
Veröffentlicht 1973

PCSK9 inhibitors and cardiovascular disease: heralding a new therapeutic era

von Chapman, M. John, Stock, Jane K., Ginsberg, Henry N.
Veröffentlicht in Curr Opin Lipidol (2015)

Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: a recap

von Parhofer, Klaus G, Chapman, M John, Nordestgaard, Børge G
Veröffentlicht in Eur Heart J Suppl (2020)

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors

von Chapman, M. John, Le Goff, Wilfried, Guerin, Maryse, Kontush, Anatol
Veröffentlicht 2010

New dimension of statin action on apoB atherogenicity

von Chapman, M. John, Caslake, Muriel, Packard, Chris, McTaggart, Fergus
Veröffentlicht in Clin Cardiol (2007)

Distinct HDL subclasses present similar intrinsic susceptibility to oxidation by HOCl

von Chantepie, Sandrine, Malle, Ernst, Sattler, Wolfgang, Chapman, M. John, Kontush, Anatol
Veröffentlicht 2009

Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?

von Dallinga-Thie, Geesje M., Kroon, Jeffrey, Borén, Jan, Chapman, M. John
Veröffentlicht in Curr Cardiol Rep (2016)

High-Density Lipoprotein (HDL) Particle Subpopulations in Heterozygous Cholesteryl Ester Transfer Protein (CETP) Deficiency: Maintenance of Antioxidative Activity

von Chantepie, Sandrine, Bochem, Andrea E., Chapman, M. John, Hovingh, G. Kees, Kontush, Anatol
Veröffentlicht 2012

Postprandial lipemia enhances the capacity of large HDL2 particles to mediate free cholesterol efflux via SR-BI and ABCG1 pathways in type IIB hyperlipidemia

von Julia, Zélie, Duchene, Emilie, Fournier, Natalie, Bellanger, Natacha, Chapman, M. John, Le Goff, Wilfried, Guerin, Maryse
Veröffentlicht 2010

Lipoprotein(a) is Markedly More Atherogenic than LDL: An Apolipoprotein B-based Genetic Analysis

von Björnson, Elias, Adiels, Martin, Taskinen, Marja-Riitta, Burgess, Stephen, Chapman, M. John, Packard, Chris J, Borén, Jan
Veröffentlicht in J Am Coll Cardiol (2024)

Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: Relevance to antioxidative function

von Davidson, W. Sean, Silva, R.A. Gangani D., Chantepie, Sandrine, Lagor, William R., Chapman, M. John, Kontush, Anatol
Veröffentlicht 2009

Interleukin-6 Protects Human Macrophages from Cellular Cholesterol Accumulation and Attenuates the Proinflammatory Response

von Frisdal, Eric, Lesnik, Philippe, Olivier, Maryline, Robillard, Paul, Chapman, M. John, Huby, Thierry, Guerin, Maryse, Le Goff, Wilfried
Veröffentlicht 2011

Statin action enriches HDL3 in polyunsaturated phospholipids and plasmalogens and reduces LDL-derived phospholipid hydroperoxides in atherogenic mixed dyslipidemia

von Orsoni, Alexina, Thérond, Patrice, Tan, Ricardo, Giral, Philippe, Robillard, Paul, Kontush, Anatol, Meikle, Peter J., Chapman, M. John
Veröffentlicht in J Lipid Res (2016)

Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics

von Boden, William E, Bhatt, Deepak L, Toth, Peter P, Ray, Kausik K, Chapman, M John, Lüscher, Thomas F
Veröffentlicht in Eur Heart J (2020)

Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissues

von Huby, Thierry, Doucet, Chantal, Dachet, Christiane, Ouzilleau, Betty, Ueda, Yukihiko, Afzal, Veena, Rubin, Edward, Chapman, M. John, Lesnik, Philippe
Veröffentlicht 2006

Beyond cardiovascular medicine: potential future uses of icosapent ethyl

von Bhatt, Deepak L, Hull, Mark A, Song, Mingyang, Van Hulle, Carol, Carlsson, Cindy, Chapman, M John, Toth, Peter P
Veröffentlicht in Eur Heart J Suppl (2020)